Journal article

Publication year: 2016

Pages: 546-551

Journal: Digestive Diseases

Volume number: 34

Issue number: 5

ISSN: 0257-2753

eISSN: 1421-9875

DOI Link: https://doi.org/10.1159/000445260

Publisher: Karger Publishers

Abstract: 
Background: Although the gastrointestinal (GI) tract including its related organs is not generally regarded as one of the primary organ systems of primary and secondary vasculitic disorders, there are numerous mechanisms of these diseases operative in or around the different structures and compartments of the GI tract. Key Messages: A majority of the respective clinical symptoms and problems are linked to an alteration of (peri) vascular homeostasis. Alteration of perivascular matrix metabolism can also affect the functional integrity and motility of the GI tract. Apart from the specific GI phenomena of the individual diseases as outlined in detail in this review, the epidemiology of GI involvement follows in general the characteristics of the respective underlying systemic disease. In addition, gender and age do neither influence the occurrence nor the severity of the GI manifestations significantly. With respect to clinical symptoms, vasculitides may result in abdominal pain, bleeding, ileus, intestinal necrosis and hematochezia because of reduced blood flow and hyper-acute occlusion in the antiphospholipid syndrome. Small-bowel involvement in vasculitic entities can cause pseudoobstruction, obstruction, malabsorption and bacterial overgrowth. Laboratory parameters can point to specific diseases but are frequently nonspecific. Thus, if biopsy fails or in unclear endoscopic situations, a variety of imaging techniques including Doppler ultrasound, abdominal CT, MRI and angiography are used and required for identification and localization of the underlying disease. Therapeutic strategies in vasculitides usually include corticosteroids and immunosuppressants, for example, cyclophosphamide in granulomatosis with polyangiitis and in panarteriitis nodosa but also biologics such as rituximab in ANCA-associated vasculitides. Virostatic drugs including interferon-alpha and ribavirin can be used in hepatitis B-and C-triggered vasculitides such as panarteriitis nodosa and hepatitis C-associated cryoglobulinemia. Conclusions: Immediate diagnostic and therapeutic steps of action need to be performed if vasculitis of the GI tract is suspected in order to avoid irreversible damage to organs and to improve the well-being and life of the affected patient. (C) 2016 S. Karger AG, Basel

Harvard Citation style: Mueller-Ladner, U. (2016) Gut and Liver in Vasculitic Disorders, Digestive Diseases, 34(5), pp. 546-551. https://doi.org/10.1159/000445260

APA Citation style: Mueller-Ladner, U. (2016). Gut and Liver in Vasculitic Disorders. Digestive Diseases. 34(5), 546-551. https://doi.org/10.1159/000445260